Novavax shares jumped on fears of a possible plague outbreak. The illness is unconfirmed and bacterial, and the story reports no new sales, so its business outlook is unchanged.
The story does not report a new vaccine order, sale, or product change for Novavax. Plague has not been confirmed, and it is a bacterial illness treated with antibiotics. Novavax's vaccines mainly target viruses, so the share jump does not show a change in its business.
Moderna shares rose as vaccine stocks gained on outbreak fears. Plague is unconfirmed, and the story reports no new Moderna sales or orders, so its business outlook is unchanged.
Emergent BioSolutions shares rose as traders reacted to fears of an outbreak. Plague is unconfirmed, and the story reports no new company contract or sales, so its business outlook is unchanged.
Follow Novavax Inc. (NVAX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for NVAX